efaproxiral has been researched along with carboplatin in 3 studies
| Studies (efaproxiral) | Trials (efaproxiral) | Recent Studies (post-2010) (efaproxiral) | Studies (carboplatin) | Trials (carboplatin) | Recent Studies (post-2010) (carboplatin) |
|---|---|---|---|---|---|
| 76 | 13 | 10 | 12,895 | 4,001 | 5,244 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Donnelly, ET; Kelley, M; Rockwell, S | 1 |
| Ayoub, J; Boyd, AP; Cagnoni, PJ; Choy, H; Curran, WJ; Hamburg, S; Kleinberg, L; Kreisman, H; Nabid, A; Roa, W; Scott, C; Smith, C; Souhami, L; Spanos, W; Stea, B | 1 |
| Donnelly, ET; Liu, Y; Rockwell, S | 1 |
1 trial(s) available for efaproxiral and carboplatin
| Article | Year |
|---|---|
Phase II multicenter study of induction chemotherapy followed by concurrent efaproxiral (RSR13) and thoracic radiotherapy for patients with locally advanced non-small-cell lung cancer.
Topics: Adult; Aged; Aniline Compounds; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Propionates; Radiation-Sensitizing Agents; Survival Analysis | 2005 |
2 other study(ies) available for efaproxiral and carboplatin
| Article | Year |
|---|---|
Effects of RSR13 and oxygen on the cytotoxicity of cisplatin and carboplatin to EMT6 mouse mammary tumor cells in vitro and in vivo.
Topics: Aniline Compounds; Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Survival; Cisplatin; Combined Modality Therapy; Female; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Oxygen; Oxygen Inhalation Therapy; Propionates; Tumor Cells, Cultured | 2004 |
Efaproxiral (RSR13) plus oxygen breathing increases the therapeutic ratio of carboplatin in EMT6 mouse mammary tumors.
Topics: Alkylating Agents; Aniline Compounds; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Female; Male; Mammary Neoplasms, Animal; Mice; Mice, Inbred BALB C; Oxygen; Propionates; Respiration; Time Factors | 2006 |